Atlas Trials

InflaRx GmbH

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch InflaRx GmbH

RecordFirmDate
Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa (NCT06555328)InflaRx GmbH2025-01-02
Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum (NCT05964413)InflaRx GmbH2023-11-01
Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. (NCT04812535)InflaRx GmbH2021-03-31
Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia (NCT04333420)InflaRx GmbH2020-03-31
Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum (NCT03971643)InflaRx GmbH2019-05-16
Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis. (NCT03895801)InflaRx GmbH2019-04-03
Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA (NCT03712345)InflaRx GmbH2018-10-15
Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT03487276)InflaRx GmbH2018-02-26

Track InflaRx GmbH automatically

Every clearance here is in the API, with alerts when new ones post.